Financial Performance - The company reported a significant increase in revenue, reaching $1.5 billion, representing a 25% year-over-year growth [15]. - The company achieved operating revenue of CNY 303,956.79 million in 2024, representing a year-on-year growth of 47.14% [25]. - The net profit attributable to shareholders reached CNY 20,264.98 million, an increase of 20.13% compared to the previous year [25]. - The net profit after deducting non-recurring gains and losses was CNY 17,190.34 million, showing a significant growth of 98.98% year-on-year [25]. - The company reported a significant increase in revenue from its top five customers, which grew by over 50% year-on-year [39]. - The company reported a significant increase in revenue, achieving a total of $150 million for the last quarter, representing a 25% year-over-year growth [157]. - The company achieved operating revenue of 3,039.57 million RMB, an increase of 47.14% compared to the previous year, with operating costs rising by 45.97% to 2,255.46 million RMB [99]. - The company reported a net profit attributable to shareholders after deducting non-recurring gains and losses was 172 million RMB, representing a year-on-year growth of 98.98% [38]. Dividends and Shareholder Returns - The company plans to distribute a cash dividend of RMB 1.50 per 10 shares, totaling RMB 45,681,688.20 (including tax) based on a total share capital of 306,210,771 shares after deducting shares in the repurchase account [6]. - The company distributed a cash dividend of 3.50 RMB per 10 shares, totaling 10,652.06 million RMB, which represents 52.56% of the net profit attributable to ordinary shareholders [189]. - The total amount of cash dividends, including share repurchases, reached 21,653.86 million RMB, exceeding the net profit by 106.85% [189]. - The cumulative cash dividends over the last three fiscal years totaled CNY 35,595.65 million, resulting in a cash dividend payout ratio of 173.13% [191]. Research and Development - The company is investing $50 million in R&D for new technologies aimed at enhancing product performance and efficiency [15]. - The R&D investment as a percentage of operating revenue was 7.28%, down 2.69 percentage points from the previous year [26]. - R&D investment totaled ¥22,139.81 million in the current year, a 7.47% increase from the previous year, with R&D expenses accounting for 7.28% of revenue, down 2.69 percentage points [74]. - The company has developed advanced stainless steel processing techniques, which are now utilized in the production of gas cabinet modules, showcasing innovation in manufacturing processes [159]. - The ongoing R&D efforts are aligned with major national projects, emphasizing the company's commitment to innovation and industry leadership [159]. Market Expansion and Strategy - Market expansion efforts include entering three new international markets, projected to increase overall market share by 15% [15]. - The company is exploring potential acquisitions to bolster its technology portfolio, with a budget of $100 million allocated for this purpose [15]. - The company is focused on expanding its market presence through overseas capacity expansion and establishing wholly-owned subsidiaries [82]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of $20 million earmarked for potential deals [157]. - The company aims to strengthen collaboration with major clients and expand market share by transitioning from single parts to components and system modules [141]. Governance and Compliance - The company has established a robust internal control and governance structure to manage risks and protect shareholder rights, ensuring sustainable development [50]. - The company adheres to strict information disclosure regulations, maintaining transparency in operations and preventing insider trading through rigorous management practices [51]. - The company has not faced any significant issues regarding independence from its controlling shareholders or related party transactions [149]. - The company held its first extraordinary shareholders' meeting of 2024 on March 22, 2024, with all proposals approved [149]. - The company has implemented a comprehensive training program to enhance management capabilities and employee integration, focusing on strategic development needs [183]. Operational Efficiency - Operating expenses were reduced by 10%, contributing to an increase in net income to $300 million, up from $250 million last year [15]. - The company has upgraded its common technology platform for semiconductor precision components, which has led to significant cost savings of over one million yuan annually by avoiding potential quality issues [46]. - The company has implemented a digital management system for tool management, improving efficiency and reducing costs [79]. - The company has established a flexible manufacturing system that enhances product iteration efficiency, providing highly adaptable solutions for the semiconductor equipment industry [43]. - The company has successfully launched production at its Nantong facility, contributing to performance, while the Beijing facility has partially completed acceptance, enhancing supply capacity in North China [44][45]. Risks and Challenges - There are no significant risks that could materially affect the company's operations during the reporting period [4]. - The company faces risks related to management capabilities due to continuous growth in production scale and organizational complexity [87]. - The company is exposed to financial risks including fluctuations in gross profit margin and potential increases in accounts receivable and inventory levels [89]. - The company has not reported any non-operating fund occupation by controlling shareholders or related parties [9]. - The company has not experienced any violations of decision-making procedures regarding external guarantees [10]. Human Resources - The company has implemented a comprehensive talent management system, optimizing its career development and compensation structures to attract and retain talent [47]. - The number of R&D personnel has increased to 548, representing 16.81% of the total workforce, down from 18.89% in the previous period [81]. - The average salary for R&D personnel has risen to RMB 23.67 million, compared to RMB 22.65 million in the previous period [81]. - The total remuneration for all directors, supervisors, and senior management at the end of the reporting period amounted to CNY 14.72 million [166]. - The total remuneration for core technical personnel at the end of the reporting period amounted to CNY 6.73 million [166]. Strategic Partnerships and Acquisitions - A new strategic partnership has been established with a leading tech firm, expected to enhance product offerings and drive innovation [15]. - The company plans to acquire 100% equity of Beijing Yisheng Precision Semiconductor Co., Ltd. for no more than 800 million yuan, aiming to enhance business synergy through product complementarity and resource sharing [48]. - The company is pursuing a strategic investment to acquire a controlling stake in Zhejiang Poxin Electronics Technology Co., Ltd., which holds 96.56% of the international gas transmission system manufacturer Compart, enhancing its global supply chain capabilities [49]. - The company is actively involved in multiple strategic partnerships and investments, indicating a robust approach to market expansion and technological advancement [160]. - The company plans to acquire a 21.58% stake in Compart, a leader in gas transmission systems, enhancing its vertical integration capabilities and global business platform [71].

Financial Performance - The company's operating revenue for Q1 2025 was CNY 76,193.42 million, an increase of 8.62% compared to CNY 70,147.60 million in the same period last year[3]. - The net profit attributable to shareholders decreased by 136.67% to -CNY 2,215.69 million from CNY 6,042.96 million year-on-year[3]. - Total operating revenue for Q1 2025 reached ¥761,934,162.14, an increase of 8.6% compared to ¥701,476,021.12 in Q1 2024[17]. - Net profit for Q1 2025 was a loss of ¥33,810,178.34, compared to a profit of ¥50,826,577.08 in Q1 2024[18]. - Operating profit for Q1 2025 was a loss of ¥30,078,404.23, down from a profit of ¥67,215,203.83 in Q1 2024[17]. - The company's total equity decreased to ¥4,668,922,499.79 in Q1 2025 from ¥4,699,031,695.31 in Q1 2024[15]. - Basic and diluted earnings per share for Q1 2025 were both -¥0.07, compared to ¥0.29 in Q1 2024[18]. Cash Flow - The net cash flow from operating activities was CNY 144.95 million, a significant recovery from -CNY 8,046.50 million in the previous year[3]. - In Q1 2025, the cash inflow from operating activities was CNY 790,053,802.93, a significant increase of 49% compared to CNY 530,126,166.70 in Q1 2024[20]. - The net cash flow from operating activities turned positive at CNY 1,449,459.10, recovering from a loss of CNY 80,464,953.10 in the same quarter last year[20]. - The company’s cash flow statement for Q1 2025 indicates ongoing financial challenges, with significant losses reported[19]. - The ending cash and cash equivalents balance decreased to CNY 1,188,903,291.84 from CNY 1,207,722,867.11, reflecting a decline of 1.5% year-over-year[21]. - The company received CNY 72,588,969.38 in tax refunds, significantly higher than CNY 61,571.52 in Q1 2024, indicating improved cash flow management[20]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 847,401.00 million, a 1.41% increase from CNY 835,655.97 million at the end of the previous year[4]. - Total liabilities increased to ¥3,805,087,477.12 in Q1 2025, compared to ¥3,657,528,028.71 in Q1 2024[15]. - The company's total current assets amounted to approximately CNY 3.77 billion, an increase from CNY 3.73 billion as of December 31, 2024, reflecting a growth of about 1.5%[13]. - The equity attributable to shareholders decreased by 0.40% to CNY 456,971.83 million from CNY 458,817.42 million at the end of the previous year[4]. Research and Development - R&D investment totaled CNY 5,469.71 million, representing 7.18% of operating revenue, up from 6.71% in the previous year[4]. - R&D expenses increased by CNY 7.65 million for key technology breakthroughs[6]. - Research and development expenses for Q1 2025 were ¥54,697,141.01, an increase from ¥47,047,391.14 in Q1 2024[17]. Shareholder Information - The top shareholder, Guotou (Shanghai) Venture Capital Management Co., holds 37,645,989 shares, representing 12.29% of total shares[10]. - The second-largest shareholder, Liaoning Kefa Industrial Co., Ltd., holds 14,800,000 shares, accounting for 4.83% of total shares[10]. - There are no significant changes in the shareholder structure or any related party transactions reported during the period[11]. Operating Costs - Total operating costs for Q1 2025 were ¥773,272,351.97, up 16.2% from ¥665,495,824.85 in Q1 2024[17]. - Cash outflow for purchasing goods and services was CNY 420,636,277.60, up from CNY 349,020,052.07, reflecting a 20.5% increase year-over-year[20]. - Total cash outflow for operating activities was CNY 788,604,343.83, up from CNY 610,591,119.80, representing a 29% increase year-over-year[20]. Investment Activities - The cash inflow from investment activities was CNY 10,252,868.67, a decrease of 98.9% from CNY 912,475,920.00 in Q1 2024[21]. - The net cash flow from investment activities was negative at CNY -207,057,779.30, compared to CNY -347,148,758.24 in the previous year, indicating a reduced loss[21]. - Cash inflow from financing activities was CNY 242,887,552.60, an increase of 13.4% from CNY 214,134,954.82 in Q1 2024[21]. - The net cash flow from financing activities improved to CNY 154,488,962.80, compared to CNY 94,237,960.43 in the same quarter last year, marking a 64% increase[21].

中信证券股份有限公司 关于沈阳富创精密设备股份有限公司 为子公司申请综合授信额度提供担保的核查意见 中信证券股份有限公司（以下简称"中信证券"、"保荐机构"）作为沈阳 富创精密设备股份有限公司（以下简称"富创精密"、"公司"）首次公开发行 股票并在科创板上市的保荐人。根据《证券发行上市保荐业务管理办法》《上海 证券交易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管指 引第 1 号—规范运作》《科创板上市公司持续监管办法（试行）》等有关规定， 对富创精密为子公司申请综合授信额度提供担保的事项进行了核查，核查情况及 核查意见如下： 一、担保情况概述 为满足公司全资子公司生产经营和业务发展的需求，公司于2025年4月29日召 开公司第二届董事会第十八次会议和第二届监事会第十五次会议，审议并通过了 《关于公司2025年度对外担保预计的议案》，本次担保事项尚需提交公司股东大 会审议。 为满足公司全资子公司南通富创、北京富创的生产经营需要，提升经营效益， 南通富创拟申请项目贷款，贷款金额不超过80,000万元；北京富创拟申请综合授 信，金额不超过50,000万元。公司就南通富创、北京富创本次贷款事项尚未签订 ...

内部控制审计报告 2024 年 12 月 31 日 内部控制审计报告 信会师报字[2025]第 ZA12728 号 沈阳富创精密设备股份有限公司全体股东: 沈阳富创精密设备股份有限公司 您可使用手机"扫一扫"或进入"注册 按照《企业内部控制审计指引》及中国注册会计师执业准则的相 关要求,我们审计了沈阳富创精密设备股份有限公司(以下简称富创 精密）2024年12月31日的财务报告内部控制的有效性。 一、企业对内部控制的责任 按照《企业内部控制基本规范》、《企业内部控制应用指引》、《企 业内部控制评价指引》的规定,建立健全和有效实施内部控制,并评 价其有效性是富创精密董事会的责任。 二、注册会计师的责任 我们的责任是在实施审计工作的基础上,对财务报告内部控制的 有效性发表审计意见,并对注意到的非财务报告内部控制的重大缺陷 进行披露。 三、内部控制的固有局限性 内部控制具有固有局限性,存在不能防止和发现错报的可能性。 此外,由于情况的变化可能导致内部控制变得不恰当,或对控制政策 和程序遵循的程度降低,根据内部控制审计结果推测未来内部控制的 有效性具有一定风险。 内部控制审计报告 第1页 T信会计师事务所(特殊普通合 ...

中信证券股份有限公司 关于沈阳富创精密设备股份有限公司 2025 年度日常 关联交易预计的核查意见 中信证券股份有限公司（以下简称"中信证券"、"保荐人"）作为沈阳富 创精密设备股份有限公司（以下简称"富创精密"、"公司"）首次公开发行股 票并在科创板上市的保荐人，根据《证券发行上市保荐业务管理办法》《上海证 券交易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管指引 第 1 号—规范运作》《科创板上市公司持续监管办法（试行）》等有关规定，对 富创精密 2025 年度日常关联交易预计的核查意见事项进行了核查，核查情况及 核查意见如下： 一、日常关联交易基本情况 （一）日常关联交易履行的审议程序 2025 年 4 月 18 日、2025 年 4 月 29 日，公司分别召开第二届董事会独立 董事专门会议 2024 年第三次会议、第二届董事会第十八次会议，审议通过了《关 于公司 2025 年度日常关联交易预计的议案》，非关联独立董事认为：公司预计 2025 年度与关联人发生的关联交易遵循了公平、自愿的交易原则，不存在违反 法律、法规、《沈阳富创精密设备股份有限公司章程》及相关制度的情形，关联 交易定价公 ...

沈阳富创精密设备股份有限公司 鉴证报告 2024 年度 您可使用手机"扫一扫"或进入"注册会 关于沈阳富创精密设备股份有限公司 2024年度募集资金存放与 使用情况专项报告的鉴证报告 信会师报字[2025]第ZA12729号 沈阳富创精密设备股份有限公司全体股东: 我们接受委托,对后附的沈阳富创精密设备股份有限公司(以下 简称"富创精密"） 2024年度募集资金存放与使用情况专项报告(以 下简称"募集资金专项报告")执行了合理保证的鉴证业务。 一、董事会的责任 富创精密董事会的责任是按照中国证券监督管理委员会《上市公 司监管指引第2号 -- 上市公司募集资金管理和使用的监管要求 (2022年修订)》(证监会公告(2022)15号)、《上海证券交易所 科创板上市公司自律监管指引第1号 -- 规范运作》以及《上海证券 交易所上市公司自律监管指南第1号 -- 公告格式》的相关规定编制 募集资金专项报告。这种责任包括设计、执行和维护与募集资金专项 投告编制相关的内部控制,确保募集资金专项报告真实、准确、完整, 不存在虚假记载、误导性陈述或重大遗漏。 二、注册会计师的责任 我们的责任是在执行鉴证工作的基础上对募集资金专 ...

沈阳富创精密设备股份有限公司 审计报告及财务报表 二〇二四年度 1. 41 7 1 1 7 1 您可使用手机"扫一扫"或进入"注册会议 沈阳富创精密设备股份有限公司 审计报告及财务报表 (2024年01月01日至 2024年12月31日止) | 目录 | 页次 | | --- | --- | | 审计报告 | 1-6 | | 财务报表 | | | 合并资产负债表和母公司资产负债表 | 1-4 | | 合并利润表和母公司利润表 | ર-୧ | | 合并现金流量表和母公司现金流量表 | 7-8 | | 合并所有者权益变动表和母公司所有者权益变动表 | 9-12 | | 财务报表附注 | 1-123 | 立信会计师事务所(特殊普通合伙) DO CHINA SHU LUN PAN CERTIFIED PUBLIC ACCOUNTANTS 审计报告 信会师报字[2025]第 ZA12727 号 沈阳富创精密设备股份有限公司全体股东; 一、审计意见 我们审计了沈阳富创精密设备股份有限公司(以下简称富创精密) 财务报表,包括 2024年 12 月 31 日的合并及母公司资产负债表,2024 年度的合并及母公司利润表、合并及 ...

中信证券股份有限公司 关于沈阳富创精密设备股份有限公司 （二）募集资金本报告期使用金额及期末余额情况 截至2023年12月31日，公司已使用募集资金3,345,131,702.54元，其中：（1） 投入集成电路装备零部件全工艺智能制造生产基地1,073,303,127.44元；（2）承 诺项目补充流动资金投入600,000,000.00元；（3）超募资金补充流动资金投入 1,038,000,000.00元；（4）购买理财产品500,000,000.00元；（5）股份回购 133,828,575.10元（含印花税、交易佣金等交易费用）。此外公司取得闲置募集资 1 金现金管理收益和利息收入合计39,427,870.30元，使用募集资金支付发行费用 263,099,513.09元、支付银行手续费9,289.29元。募集资金余额为89,098,112.04 元。 截至2024年12月31日，公司募集资金专用账户余额合计为307,391,872.74元。 公司募集资金使用与结存情况如下表： 单位：元 2024 年度募集资金存放与使用情况的核查意见 中信证券股份有限公司（以下简称"中信证券"、"保荐人"）作为沈阳富创 精 ...

沈阳富创精密设备股份有限公司 专项报告 2024 年度 您可使用手机"扫一扫"或进入"注册分 关于沈阳富创精密设备股份有限公司 非经营性资金占用及其他关联资金往来情况 的专项报告 信会师报字[2025]第 ZA12730 号 沈阳富创精密设备股份有限公司全体股东: 我们审计了沈阳富创精密设备股份有限公司(以下简称"富创精 密")2024年度的财务报表,包括 2024年 12 月 31 日的合并及母公司 资产负债表、2024 年度合并及母公司利润表、合并及母公司现金流 量表、合并及母公司所有者权益变动表和相关财务报表附注,并于 2025 年 4 月 29 日出具了报告号为信会师报字[2025]第 ZA12727 号的 无保留意见审计报告。 富创精密管理层根据中国证券监督管理委员会《上市公司监管指 引第 8 号 -- 上市公司资金往来、对外担保的监管要求》(证监会公 告(2022)26 号)和上海证券交易所《科创板上市公司自律监管指 南第 7 号 -- 年度报告相关事项》的相关规定编制了后附的 2024 年 度非经营性资金占用及其他关联资金往来情况汇总表(以下简称"汇 总表")。 编制汇总表并确保其真实、准确、合 ...

富创精密公告，2025年第一季度营收为7.62亿元，同比增长8.62%；净亏损2215.69万元，去年同期净利 润6042.96万元。 ...